Ipca Laboratories (BOM:524494) Interest Expense : ₹-918 Mil (TTM As of Dec. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Ipca Laboratories Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Ipca Laboratories's interest expense for the three months ended in Dec. 2024 was ₹ -168 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₹-918 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Ipca Laboratories's Operating Income for the three months ended in Dec. 2024 was ₹ 3,646 Mil. Ipca Laboratories's Interest Expense for the three months ended in Dec. 2024 was ₹ -168 Mil. Ipca Laboratories's Interest Coverage for the quarter that ended in Dec. 2024 was 21.69. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Ipca Laboratories Interest Expense Historical Data

The historical data trend for Ipca Laboratories's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipca Laboratories Interest Expense Chart

Ipca Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Interest Expense

Get a 7-Day Free Trial

-158.40

-86.10

-72.40

-450.90

-1,372.90

Ipca Laboratories Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial															-334.00	-283.90	-240.50	-225.60	-168.10

Ipca Laboratories Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-918 Mil.

Ipca Laboratories (BOM:524494) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Ipca Laboratories's Interest Expense for the three months ended in Dec. 2024 was ₹-168 Mil. Its Operating Income for the three months ended in Dec. 2024 was ₹3,646 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was ₹0 Mil.

Ipca Laboratories's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2024 )	/	Interest Expense (Q: Dec. 2024 )
	=	-1	*	3646.2	/	-168.1
	=	21.69

The higher the ratio, the stronger the company's financial strength is.

Ipca Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipca Laboratories Ltd (BOM:524494) » Definitions » Interest Expense

Traded in Other Exchanges

IPCALAB:India

Address

125, Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067

Website

https://www.ipca.com

Ipca Laboratories Ltd is a pharmaceutical company. The company's principal activity is the Development, Manufacturing, and Marketing of Pharmaceuticals Products. The company's API products include Atenolol (anti-hypertensive), Chloroquine Phosphate (anti-malarial), Chlorthalidone (diuretic), Furosemide (diuretic), Hydroxychloroquine Sulphate (DMARD), Losartan. The company has only one reportable primary business segment, pharmaceuticals.

Ipca Laboratories Headlines

No Headlines